Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia
A case report and literature review
DOI:
https://doi.org/10.15419/bmrat.v5i8.465Keywords:
Immune thrombocytopenia, Prednisolone, Primary ITP, Romiplostim, SplenectomyAbstract
Immune thrombocytopenia is characterized by reduced platelet count. This condition occurs in both adults and children. The most common form of thrombocytopenia is primary ITP and autoantibodies are involved in its development. In this study, our patient was a pregnant woman with ITP who showed refractory to prednisolone and splenectomy as first and second line treatment, respectively, but the response to treatment with Romiplostim and platelet count was favorable, and delivery was reported without fetal complications.
Downloads
Published
Issue
Section
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
